Belle and Elin dive into this week's healthtech headlines: Time's Top 500 Healthtech Companies list, Sword Health's discount buyout of Headspace, why cycle syncing workouts have women split, and what's at stake as the FDA weighs approval for the first psychedelic medicine.
00:00 - Intro
02:58 - Time's Top 500 Healthtech Companies & Headspace's $300m Sale to Sword Health
16:37 - Menstrual Fitness: Why Some Women Are Cycle Syncing Their Workouts
30:27 - FDA Hearing Weighs Access and Safety for Psychedelic Medicine
39:50 - Outro
🗞 Grab the newsletter at www.healthtechpigeon.com
✍️ Apply to be a podcast guest using this form: https://share.hsforms.com/1PkAwCjniQj..
📖 Learn more about the SomX team at https://somx.health
